Asian Pacific Association for the Study of the Liver clinical practice guidelines on liver transplantation Dong-Sik KimYoung-In Yoonfor Asian Pacific Association for Study of Liver (APASL) Guidelines 28 February 2024 Pages: 299 - 383
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update Yimin MaoShiwu Mathe Technology Committee on DILI Prevention, Management, Chinese Medical Biotechnology Association; Study Group on Drug-Induced Liver Disease, Chinese Society of Hepatology, Chinese Medical Association Guidelines 24 February 2024 Pages: 384 - 419
Artificial intelligence in liver imaging: methods and applications Peng ZhangChaofei GaoXiaolong Qi Review Article 20 February 2024 Pages: 422 - 434
Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B Min ZhangJing LiFu-Sheng Wang Original Article Open access 20 February 2024 Pages: 435 - 448
Preventing viral relapse with prophylactic tenofovir in hepatitis B carriers receiving chemotherapy: a phase IV randomized study in Taiwan Chao-Wei HsuShin-Cheh ChenChau-Ting Yeh Original Article 20 February 2024 Pages: 449 - 460
An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan Ming-Lung YuChi‐Ming TaiCheng-Yuan Peng Original Article Open access 21 January 2024 Pages: 461 - 475
Planning, implementing, and evaluating Hepatitis C virus elimination via collaborative community-based care cascade: age–period–cohort model for estimating demand from antecedent anti-HCV survey Ting-Yu LinHsiao-Hsuan JenYen-Po Yeh Original Article Open access 21 November 2023 Pages: 476 - 485
Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease Raja GanesanHaripriya GuptaKi Tae Suk Original Article 31 March 2023 Pages: 486 - 499
New prognostic model for hospitalized patients with alcoholic cirrhosis and Maddrey’s discriminant function <32 Tae Hyung KimHyung Joon YimThe Korean Acute-on-Chronic Liver Failure (KACLiF) Study Group Original Article 13 October 2023 Pages: 500 - 508
ChIP-seq analysis found IL21R, a target gene of GTF2I–the susceptibility gene for primary biliary cholangitis in Chinese Han Ziyan WuHaolong LiYongzhe Li Original Article 15 September 2023 Pages: 509 - 516
Proteome-wide Mendelian randomization highlights AIF1 and HLA-DQA2 as targets for primary sclerosing cholangitis Lanlan ChenYuexuan ZhaoGuoyue Lv Original Article 11 November 2023 Pages: 517 - 528
Dairy products intake and prevalence, incidence, and recovery of non-alcoholic fatty liver disease in Chinese population Yurou XuYouyi WangXing Liu Original Article 26 February 2024 Pages: 529 - 539
Incidence and predictors of hepatocellular carcinoma in NAFLD without diagnosed cirrhosis: a nationwide real-world U.S. study Daniel Q. HuangSally TranMindie H. Nguyen Original Article 11 December 2023 Pages: 540 - 549
OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma Juntao TanYue YuXiaoxin Wu Original Article Open access 17 April 2023 Pages: 550 - 567
Hepatocellular carcinoma (HCC) tumor microenvironment is more suppressive than colorectal cancer liver metastasis (CRLM) tumor microenvironment Sara SantagataGiuseppina ReaStefania Scala Original Article Open access 04 May 2023 Pages: 568 - 581
Distinctly altered lipid components in hepatocellular carcinoma relate to impaired T cell-dependent antitumor immunity Xue ChengWei WangXiufang Weng Original Article 12 October 2023 Pages: 582 - 594
TACE plus tyrosine kinase inhibitors and immune checkpoint inhibitors versus TACE plus tyrosine kinase inhibitors for the treatment of patients with hepatocellular carcinoma: a meta-analysis and trial sequential analysis Jiaxi LiuPeng WangHaibo Shao Original Article 16 October 2023 Pages: 595 - 609
Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma Hiroyuki SuzukiHideki IwamotoTakumi Kawaguchi Original Article Open access 21 October 2023 Pages: 610 - 622
A multicenter propensity score analysis of significance of hepatic resection type for early-stage hepatocellular carcinoma Shi-Chuan TangKai-Ling ZhangYong-Yi Zeng Original Article 25 October 2023 Pages: 623 - 635
Transferrin receptor 1 promotes hepatocellular carcinoma progression and metastasis by activating the mTOR signaling pathway Fu WangWei-Qi XuJi-Min Zhu Original Article 20 November 2023 Pages: 636 - 650
The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitors Zhen-Xin ZengJia-Yi WuMao-Lin Yan Original Article 01 December 2023 Pages: 651 - 660
Diagnostic yield and novel candidate genes by next generation sequencing in 166 children with intrahepatic cholestasis Yucan ZhengHongmei GuoZhifeng Liu Original Article 14 June 2023 Pages: 661 - 672
Skeletal muscle alterations indicate poor prognosis in cirrhotic patients: a multicenter cohort study in China Xin ZengZhi-Wen ShiWei-Fen Xie Original Article 18 June 2023 Pages: 673 - 687
Prevalence and impact on the outcome of myosteatosis in patients with cirrhosis: a systematic review and meta-analysis Aikaterini KamiliouVasileios LekakisEvangelos Cholongitas Original Article Open access 08 February 2024 Pages: 688 - 699
Response to letter to editor for risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis Jin Wook ParkJeong-Ju YooYoung Seok Kim Letter to the Editor 29 February 2024 Pages: 700 - 701
Comments on: Risk of dyslipidemia in chronic hepatitis B patients taking tenofovir alafenamide: a systematic review and meta-analysis Yan WangXiu SunQi Mei Letter to the Editor Open access 02 March 2024 Pages: 702 - 703
Is lenvatinib in combination with transarterial chemoembolization benefit for unresectable hepatocellular carcinoma (uHCC)? The age interference needs to be eliminated Sai LiYong Li Letter to the Editor 09 November 2023 Pages: 704 - 705
Editorial: The safety profile of endoscopic variceal ligation in patients with esophageal varices. Authors’ reply N. PfistererM. SchwarzT. Reiberger Letter to the Editor 23 December 2023 Pages: 706 - 707